Abstract:The morphology and microstructure of crystalline drug/polymer solid dispersions could influence their physical stability and dissolution performance. In this study, the drug crystallization mechanism within PEG, PPG, and poloxamer matrix was investigated, and the resultant microstructure of various solid dispersions of acetaminophen (ACM) and bifonazole (BFZ) in the aforementioned polymers was characterized by differential scanning calorimetry (DSC), polarized optical microscopy (POM), and wide/small-angle X-ray diffraction (WAXD/SAXS). With a stronger molecular interaction with the PEG segments, ACM decreased the crystallization onset temperature and crystallinity of PEG and poloxamers much more than BFZ. The stronger molecular interaction and better miscibility between ACM and PEG also induced a more defective lamellar structure in the ACM solid dispersions compared with that in the BFZ systems, as revealed by DSC and SAXS investigation. Observed under polarized optical microscopy, PEG, PPG, and poloxamer could all significantly improve the crystallization rate of ACM and BFZ, because of the largely reduced T-g of the solid dispersions by these low T-g polymers. Moreover, when the drug loading was below 60%, crystallization of BFZ in PEG or poloxamer occurred preferably along the radial direction of PEG spherulite, rather than the perpendicular direction, which was attributed to the geometric restriction of well-ordered polymer lamellar structure in the BFZ solid dispersions. Similar phenomena were not observed in the ACM solid dispersions regardless of the drug loading, presumably because ACM could diffuse freely across the perpendicular direction of the PEG spherulite, through the well-connected interlamellar or interfibrillar spaces produced by the defective PEG lamellar structure. The different drug-polymer interaction also caused a difference in the microstructure of polymer crystal, as well as a difference in drug distribution within the polymer matrix, which then synergistically facilitated a confined crystallization process to reduce the drug crystallite size below 100 nm.

[Overnight surgery in proctology and anesthesia type: our experience on 320 patients].

Prediction of the physical stability of amorphous solid dispersions: relationship of aging and phase separation with the thermodynamic and kinetic models along with characterization techniques

Particle size control and the interactions between drug and stabilizers in an amorphous nanosuspension system

A carbohydrate polymer is a critical variable in the formulation of drug nanocrystals: a case study of idebenone

Transformation of ABT-199 Nanocrystal Suspensions into a Redispersible Drug Product—Impact of Vacuum Drum Drying, Spray Drying and Tableting on Re-Nanodispersibility

Quercetin nanocrystals for bioavailability enhancement: impact of different functional stabilizers on in vitro/in vivo drug performances

A Nanocrystal Platform Based on Metal-Phenolic Network Wrapping for Drug Solubilization

Revealing the roles of polymers in supersaturation stabilization from the perspective of crystallization behaviors: A case of nimodipine

Roles of effective stabilizers in improving oral bioavailability of naringenin nanocrystals: maintenance of supersaturation generated upon dissolution by inhibition of drug dimerization

Formulating Food Protein-Stabilized Indomethacin Nanosuspensions into Pellets by Fluid-Bed Coating Technology: Physical Characterization, Redispersibility, and Dissolution

Preparation and characterization of stabilizer-free oily nanosuspensions

Converting nanosuspension into inhalable and redispersible nanoparticles by combined in-situ thermal gelation and spray drying

Inhibition of DPNH oxidase activity of tissues by steroid hormones.

Optimization, characterization and in vitro/vivo evaluation of azilsartan nanocrystals

Research on storage stability differences between ceftriaxone sodium products

Studies on the Drug-Loading Mechanism of Polybutylcyanocrylate Nanoparticle and Its Stability of Thermodynamics

In-situ sequential crystallization of fenofibrate and tristearin - Understanding the distribution of API in particles and stability of solid lipid microparticles from the perspective of crystallization

Molecular Mechanisms for Stabilizing Biologics in the Solid State

Crystallization of Bifonazole and Acetaminophen Within the Matrix of Semicrystalline, Peo-Ppo-Peo Triblock Copolymers

Rubusoside As a Multifunctional Stabilizer for Novel Nanocrystal-Based Solid Dispersions with a High Drug Loading: A Case Study

PEMPHIGUS AND PSYCHOLOGICAL STRESS: A REVIEW OF THE LITERATURE